Synopsis
Synopsis
0
KDMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 615-347-9
2. 7177-48-2
3. Aminobenzylpenicillin Trihydrate
4. Penbritin
5. Nci-c56086
6. Ampicillin/ampicillin Trihydrate
7. Hxq6a1n7r6
8. (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Trihydrate
9. Chebi:31209
10. Poly-cillin
11. Ampicillin Hydrate
12. Amperil
13. Ampinova
14. Trafarbiot
15. Amcap
16. Cymbi
17. D-(-)-alpha-aminobenzylpenicillin
18. (2s,5r,6r)-6-{[(2r)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Trihydrate
19. Ampicillin 3-wasser
20. Alpha-aminobenzylpenicillin Trihydrate
21. (2s,5r,6r)-6-[(2r)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
22. (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Trihydrate
23. (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid;trihydrate
24. Ccris 267
25. Unii-hxq6a1n7r6
26. (d-(-)-alpha-aminobenzyl)penicillin Trihydrate
27. Cas-7177-48-2
28. Amcill (tn)
29. Ampicilline Trihydrate
30. Dsstox_cid_83
31. Ampicillin Hydrate (jp17)
32. Dsstox_rid_75354
33. Dsstox_gsid_20083
34. Ampicillin Trihydrate, Sodium
35. Chembl453388
36. Ampicillin Hydrate [jan]
37. Ampicillin/ampicillin Monohydrate
38. Dtxsid9020083
39. Ampicillin Trihydrate [mi]
40. Hms1568g10
41. Hms2095g10
42. Hms3712g10
43. Tox21_201148
44. Ampicillin Trihydrate [vandf]
45. Mfcd00072036
46. S4148
47. Ampicillin Trihydrate [mart.]
48. Akos015915153
49. Ampicillin Trihydrate [usp-rs]
50. Ampicillin Trihydrate [who-dd]
51. Ampicillin Trihydrate [who-ip]
52. Ccg-220114
53. Ks-5251
54. Ncgc00023282-03
55. Ncgc00258700-01
56. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((2r)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, Trihydrate, (2s,5r,6r)-
57. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, Trihydrate, (2s-(2alpha,5alpha,6beta(s*)))-
58. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, Trihydrate, D- (-)-
59. Ampicillin Trihydrate [green Book]
60. Ampicillin Trihydrate [ep Monograph]
61. Ampicillin, Meets Usp Testing Specifications
62. D01251
63. 005a175
64. Sr-01000000061
65. Sr-01000000061-4
66. Ampicillin/ampicillin Trihydrate [orange Book]
67. Q27114210
68. Ampicillin Trihydrate, Vetranal(tm), Analytical Standard
69. Ampicillin Trihydrate, 96.0-100.5% Anhydrous Basis (hplc)
70. Ampicillin Trihydrate, British Pharmacopoeia (bp) Reference Standard
71. Ampicillin Trihydrate, European Pharmacopoeia (ep) Reference Standard
72. Ampicillin Trihydrate, United States Pharmacopeia (usp) Reference Standard
73. 6beta-[(2r)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic Acid Trihydrate
74. Ampicillin Trihydrate, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacidtrihydrate
76. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((2r)-2-amino-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-, Hydrate (1:3), (2s,5r,6r)-
| Molecular Weight | 403.5 g/mol |
|---|---|
| Molecular Formula | C16H25N3O7S |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 403.14132132 g/mol |
| Monoisotopic Mass | 403.14132132 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 562 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
| 1 of 2 | |
|---|---|
| Drug Name | Ampicillin trihydrate |
| Drug Label | Ampicillin trihydrate is a semisynthetic penicillin derived from the basic penicillin nucleus, 6-aminopenicillanic acid. Ampicillin is designed chemically as (2S, 5R, 6R)-6-[(R)-2-Amino-2-phenylacetamido]-3, 3-dimethyl-7-oxo-4-this-l-azabicyclo[3.2.0... |
| Active Ingredient | Ampicillin/ampicillin trihydrate |
| Dosage Form | Capsule; For suspension |
| Route | Oral |
| Strength | eq 250mg base/5ml; eq 500mg base; eq 250mg base; eq 125mg base/5ml |
| Market Status | Prescription |
| Company | Sandoz; Dava Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Ampicillin trihydrate |
| Drug Label | Ampicillin trihydrate is a semisynthetic penicillin derived from the basic penicillin nucleus, 6-aminopenicillanic acid. Ampicillin is designed chemically as (2S, 5R, 6R)-6-[(R)-2-Amino-2-phenylacetamido]-3, 3-dimethyl-7-oxo-4-this-l-azabicyclo[3.2.0... |
| Active Ingredient | Ampicillin/ampicillin trihydrate |
| Dosage Form | Capsule; For suspension |
| Route | Oral |
| Strength | eq 250mg base/5ml; eq 500mg base; eq 250mg base; eq 125mg base/5ml |
| Market Status | Prescription |
| Company | Sandoz; Dava Pharms |
API SUPPLIERS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26505
Submission : 2012-10-30
Status : Active
Type : II
Certificate Number : R1-CEP 2011-297 - Rev 03
Issue Date : 2021-10-06
Type : Chemical
Substance Number : 168
Status : Valid
Date of Issue : 2022-05-19
Valid Till : 2025-05-27
Written Confirmation Number : WC-0010
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35735
Submission : 2021-03-26
Status : Active
Type : II
Certificate Number : R0-CEP 2020-133 - Rev 00
Issue Date : 2022-04-05
Type : Chemical
Substance Number : 168
Status : Valid
NDC Package Code : 32903-014
Start Marketing Date : 2023-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41293
Submission : 2025-02-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-08-01
Pay. Date : 2016-10-14
DMF Number : 30815
Submission : 2016-08-02
Status : Active
Type : II
Certificate Number : R1-CEP 2002-178 - Rev 02
Issue Date : 2015-02-16
Type : Chemical
Substance Number : 168
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38056
Submission : 2023-03-30
Status : Active
Type : II
Certificate Number : CEP 2022-507 - Rev 00
Issue Date : 2024-05-21
Type : Chemical
Substance Number : 168
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13728
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25035
Submission : 2011-05-09
Status : Inactive
Type : II
Certificate Number : R1-CEP 2009-092 - Rev 00
Issue Date : 2016-04-04
Type : Chemical
Substance Number : 168
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13364
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13408
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13438
Submission : 1998-09-01
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26505
Submission : 2012-10-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13408
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13299
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8843
Submission : 1990-11-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13364
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13423
Submission : 1998-09-01
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11482
Submission : 1995-04-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11450
Submission : 1995-04-14
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13296
Submission : 1998-09-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11484
Submission : 1995-04-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Thickeners and Stabilizers
Coating Systems & Additives
Granulation
Solubilizers
Lubricants & Glidants
Direct Compression
Co-Processed Excipients
Empty Capsules
Controlled & Modified Release
Film Formers & Plasticizers
Parenteral
Disintegrants & Superdisintegrants
Taste Masking
Rheology Modifiers
Emulsifying Agents
Topical
Coloring Agents
API Stability Enhancers
Chewable & Orodispersible Aids
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Ampicillin Trihydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ampicillin Trihydrate manufacturer or Ampicillin Trihydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ampicillin Trihydrate manufacturer or Ampicillin Trihydrate supplier.
PharmaCompass also assists you with knowing the Ampicillin Trihydrate API Price utilized in the formulation of products. Ampicillin Trihydrate API Price is not always fixed or binding as the Ampicillin Trihydrate Price is obtained through a variety of data sources. The Ampicillin Trihydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cymbi manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cymbi, including repackagers and relabelers. The FDA regulates Cymbi manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cymbi API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cymbi manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cymbi supplier is an individual or a company that provides Cymbi active pharmaceutical ingredient (API) or Cymbi finished formulations upon request. The Cymbi suppliers may include Cymbi API manufacturers, exporters, distributors and traders.
click here to find a list of Cymbi suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cymbi DMF (Drug Master File) is a document detailing the whole manufacturing process of Cymbi active pharmaceutical ingredient (API) in detail. Different forms of Cymbi DMFs exist exist since differing nations have different regulations, such as Cymbi USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cymbi DMF submitted to regulatory agencies in the US is known as a USDMF. Cymbi USDMF includes data on Cymbi's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cymbi USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cymbi suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cymbi Drug Master File in Japan (Cymbi JDMF) empowers Cymbi API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cymbi JDMF during the approval evaluation for pharmaceutical products. At the time of Cymbi JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cymbi suppliers with JDMF on PharmaCompass.
A Cymbi CEP of the European Pharmacopoeia monograph is often referred to as a Cymbi Certificate of Suitability (COS). The purpose of a Cymbi CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cymbi EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cymbi to their clients by showing that a Cymbi CEP has been issued for it. The manufacturer submits a Cymbi CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cymbi CEP holder for the record. Additionally, the data presented in the Cymbi CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cymbi DMF.
A Cymbi CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cymbi CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cymbi suppliers with CEP (COS) on PharmaCompass.
A Cymbi written confirmation (Cymbi WC) is an official document issued by a regulatory agency to a Cymbi manufacturer, verifying that the manufacturing facility of a Cymbi active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cymbi APIs or Cymbi finished pharmaceutical products to another nation, regulatory agencies frequently require a Cymbi WC (written confirmation) as part of the regulatory process.
click here to find a list of Cymbi suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cymbi as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cymbi API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cymbi as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cymbi and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cymbi NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cymbi suppliers with NDC on PharmaCompass.
Cymbi Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cymbi GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cymbi GMP manufacturer or Cymbi GMP API supplier for your needs.
A Cymbi CoA (Certificate of Analysis) is a formal document that attests to Cymbi's compliance with Cymbi specifications and serves as a tool for batch-level quality control.
Cymbi CoA mostly includes findings from lab analyses of a specific batch. For each Cymbi CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cymbi may be tested according to a variety of international standards, such as European Pharmacopoeia (Cymbi EP), Cymbi JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cymbi USP).
